0 CHECKOUT

PRODUCT FILTERS

REGION

922
522
522
475
475

COUNTRY

465
66
48
39
39

CATEGORIES

  • 158

PRICE

233
630
1,167
2,172

PUBLISHED

57
210
889
2,172

PRODUCT TYPE

1,676
329
116
38
12
1

Central Nervous System Drugs Market Research Reports

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

Published:  June 2016
Price:  From

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

Published:  June 2016
Price:  From

Spinal Muscular Atrophy Market - Pipeline Assessment, Size, Growth, Trends, and Forecast 2015 - 2023

"Pipeline analysis of spinal muscular atrophy (SMA) market report provides with comprehensive analysis of drugs in clinical trials for treatment for spinal muscular atrophy. The report provides insights...

Published:  October 2015
Price:  From

Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Sleep Disorders, Product, by Medication

'Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Sleep Disorders (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking...

Published:  October 2015
Price:  From

Neurotech Industry 2015-2016 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System

Now in its 11th year, The Neurotechnology Industry 2015-2016 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide...

Published:  September 2015
Price:  From

Global Alzheimer's Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022

Alzheimer’s therapeutics market was esteemed at USD 8,524.9 Mn in 2015, and is relied upon to achieve USD 14,856.3 Mn by 2022, growing at a CAGR of 8.02% from 2016 to 2022. Market Insights: Alzheimer’s...

Published:  May 2016
Price:  From

India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F)

'India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key...

Published:  December 2015
Price:  From

Global Migraine Drugs Market 2016-2020

About Migraines A migraine is characterized by repeated attacks of a severe headache, nausea, vomiting, and extreme sensitivity to light and sound. Women are more prone to the disease compared to men...

Published:  May 2016
Price:  From

Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)

The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating...

Published:  December 2015
Price:  From

Alzheimer'S Disease: Pharmacuetical Drugs Vs. Medicinal Plants - Markets, Competitors and Opportunities: 2015-2020 Analysis and Forecasts

The objective of this report is to provide a detailed analysis of Alzheimer’s disease (AD) and the pharmaceutical drugs and medicinal plants used to treat and prevent it. It also provides an overview...

Published:  July 2015
Price:  From

Epilepsy Drugs Market in Europe - Market Analysis 2015-2019

About epilepsy Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and...

Published:  September 2015
Price:  From

Global Duchenne Muscular Dystrophy Drugs Market 2015-2019

About Duchenne muscular dystrophy Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness....

Published:  August 2015
Price:  From

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

The global market for AD therapeutics and diagnostics by region should reach over $6.2 billion by 2020 from $4.4 billion in 2015, at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020. This...

Published:  March 2016
Price:  From

Huntington's Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Huntington's Disease Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual...

Published:  March 2015
Price:  From

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

Published:  February 2015
Price:  From

Global Migraine Drugs Market 2015-2019

About Migraine Migraine is a complex neurological medicial condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound....

Published:  February 2015
Price:  From

Epilepsy Therapeutics Market in the APAC Region 2015-2019

About Epilepsy Therapeutics Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations...

Published:  December 2014
Price:  From

Inhaled CNS Therapeutics

Neurological disorders are highly prevalent worldwide And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden...

Published:  June 2014
Price:  From

Global Huntington's Disease Therapeutics Market 2014-2018

About Huntington's Disease Huntington's disease is a progressive neurodegenerative disorder that can be inherited from one generation to another as an autosomal dominant trait. It arises due to genetically...

Published:  October 2014
Price:  From

Global Multiple Sclerosis Drugs Market 2014-2018

About Multiple Sclerosis and Disease Types Multiple sclerosis is a chronic, inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration. The myelin sheath...

Published:  August 2014
Price:  From
Loading Indicator

Our Clients